vs
Side-by-side financial comparison of Employers Holdings, Inc. (EIG) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Employers Holdings, Inc. is the larger business by last-quarter revenue ($170.5M vs $158.6M, roughly 1.1× Stoke Therapeutics, Inc.). On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -21.3%).
Employers Holdings, Inc. is a U.S.-headquartered insurance holding company that specializes in offering workers' compensation insurance and customized risk management services primarily for small and medium-sized enterprises across the United States. It mainly serves clients in low-to-medium hazard industries, helping them mitigate workplace safety risks and meet relevant regulatory requirements for employee protection.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
EIG vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $170.5M | $158.6M |
| Net Profit | — | $112.9M |
| Gross Margin | — | — |
| Operating Margin | — | 70.2% |
| Net Margin | — | 71.2% |
| Revenue YoY | -21.3% | 3661.1% |
| Net Profit YoY | — | 528.0% |
| EPS (diluted) | — | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $170.5M | — | ||
| Q4 25 | $188.5M | — | ||
| Q3 25 | $239.3M | — | ||
| Q2 25 | $246.3M | — | ||
| Q1 25 | $202.6M | $158.6M | ||
| Q4 24 | $216.6M | $22.6M | ||
| Q3 24 | $224.0M | — | ||
| Q2 24 | $217.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $29.7M | — | ||
| Q1 25 | $12.8M | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $30.3M | — | ||
| Q2 24 | $31.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -4.7% | — | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | 7.8% | 70.2% | ||
| Q4 24 | — | -60.4% | ||
| Q3 24 | 16.4% | — | ||
| Q2 24 | 18.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -3.5% | — | ||
| Q2 25 | 12.1% | — | ||
| Q1 25 | 6.3% | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 14.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | $-0.93 | — | ||
| Q3 25 | $-0.36 | — | ||
| Q2 25 | $1.23 | — | ||
| Q1 25 | $0.52 | $1.90 | ||
| Q4 24 | $1.14 | $-0.15 | ||
| Q3 24 | $1.21 | — | ||
| Q2 24 | $1.25 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $169.9M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $955.7M | $350.1M |
| Total Assets | $3.4B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $169.9M | — | ||
| Q4 25 | $169.9M | — | ||
| Q3 25 | $172.4M | — | ||
| Q2 25 | $78.1M | — | ||
| Q1 25 | $100.4M | $274.8M | ||
| Q4 24 | $68.4M | $128.0M | ||
| Q3 24 | $173.9M | — | ||
| Q2 24 | $126.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $19.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $955.7M | — | ||
| Q4 25 | $955.7M | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | $350.1M | ||
| Q4 24 | $1.1B | $229.0M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | — | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $3.5B | — | ||
| Q1 25 | $3.6B | $406.9M | ||
| Q4 24 | $3.5B | $271.6M | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.5B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | — | ||
| Q3 25 | $29.4M | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $14.6M | $131.8M | ||
| Q4 24 | $76.4M | $-23.2M | ||
| Q3 24 | $51.0M | — | ||
| Q2 24 | $11.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $44.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $131.7M | ||
| Q4 24 | $76.3M | $-23.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 23.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 83.0% | ||
| Q4 24 | 35.2% | -102.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 1.14× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | 0.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
